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Abstract
Background: Pregnant women consume caffeine daily. The aim of this study was to examine the association
between maternal caffeine intake from different sources and (a) gestational length, particularly the risk for
spontaneous preterm delivery (PTD), and (b) birth weight (BW) and the baby being small for gestational age (SGA).
Methods: This study is based on the Norwegian Mother and Child Cohort Study conducted by the Norwegian
Institute of Public Health. A total of 59,123 women with uncomplicated pregnancies giving birth to a live singleton
were identified. Caffeine intake from different sources was self-reported at gestational weeks 17, 22 and 30.
Spontaneous PTD was defined as spontaneous onset of delivery between 22+0 and 36+6 weeks (n = 1,451). As
there is no consensus, SGA was defined according to ultrasound-based (Marsal, n = 856), population-based
(Skjaerven, n = 4,503) and customized (Gardosi, n = 4,733) growth curves.
Results: The main caffeine source was coffee, but tea and chocolate were the main sources in women with low
caffeine intake. Median pre-pregnancy caffeine intake was 126 mg/day (IQR 40 to 254), 44 mg/day (13 to 104) at
gestational week 17 and 62 mg/day (21 to 130) at gestational week 30. Coffee caffeine, but not caffeine from other
sources, was associated with prolonged gestation (8 h/100 mg/day, P <10-7). Neither total nor coffee caffeine was
associated with spontaneous PTD risk. Caffeine intake from different sources, measured repeatedly during
pregnancy, was associated with lower BW (Marsal-28 g, Skjaerven-25 g, Gardosi-21 g per 100 mg/day additional
total caffeine for a baby with expected BW 3,600 g, P <10-25). Caffeine intake of 200 to 300 mg/day increased the
odds for SGA (OR Marsal 1.62, Skjaerven 1.44, Gardosi 1.27, P <0.05), compared to 0 to 50 mg/day.
Conclusions: Coffee, but not caffeine, consumption was associated with marginally increased gestational length
but not with spontaneous PTD risk. Caffeine intake was consistently associated with decreased BW and increased
odds of SGA. The association was strengthened by concordant results for caffeine sources, time of survey and
different SGA definitions. This might have clinical implications as even caffeine consumption below the
recommended maximum (200 mg/day in the Nordic countries and USA, 300 mg/day according to the World
Health Organization (WHO)) was associated with increased risk for SGA.
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Background
There is increasing epidemiological evidence that maternal
nutrition influences the course of pregnancy as well as
fetal growth and development and the risk of disease later
in life [1-3]. Maternal diet should ideally supply all vital
nutrients but does also, irrespective of composition, con-
tribute contaminants and compounds with pharmacologi-
cal activity that may have adverse effects. Caffeine is a
xanthine alkaloid found primarily in coffee, tea, cocoa,
energy drinks and some soft drinks, and is thus consumed
on a daily basis all over the world. Caffeine passes the pla-
cental barrier freely; the fetus does not express the main
enzymes that inactivate it [4,5], and caffeine metabolites
have been found to accumulate in the fetal brain [6,7]. In
2005, a Scandinavian expert committee concluded that
high caffeine intake may harm the fetus [5]. The current
World Health Organization (WHO) guidelines recom-
mend a caffeine intake below 300 mg/day during preg-
nancy [8], while the American College of Obstetricians
and Gynecologists and the Norwegian Food Safety
Authority concur with the Nordic Nutrition Recommen-
dations (NNR), recommending a maximum caffeine intake
of 200 mg/day [9-11].
Human studies on adverse effects of caffeine have inves-
tigated spontaneous abortion, preterm delivery (PTD),
fetal death, congenital malformations and fetal growth
restriction, with conflicting results for all outcomes
[12-23]. PTD and small for gestational age (SGA) at birth
are the pregnancy outcomes accounting for most of all
neonatal mortality, as well as short-term and long-term
morbidity [24-27]. Both are common, complex conditions;
the respective prevalences in the Norwegian population
are around 7% and 5% [28]. Despite these prevalences, the
complexity makes it difficult to measure the effect of a sin-
gle environmental factor, except in large studies. While
some studies have found a higher risk for PTD [29]
or early PTD [30] with increasing caffeine intake, most
studies on caffeine intake have found no significant asso-
ciation with gestational length as summarized in the meta-
analysis by Maslova et al.[31] and in the comprehensive
review by Peck et al.[20]. Although PTD is a heteroge-
neous pregnancy outcome with different etiologies (for
example, for early versus late PTD or for iatrogenic versus
spontaneous PTD [32]) it has mostly been studied as one
entity, which may obscure associations with subtypes of
PTD.
Approximately half of all studies report an adverse
effect of caffeine intake on BW, while others have not
found any significant associations. Comparability among
these studies is problematic due to the use of different
standard growth curves or to incomplete or inaccurate
assessment of caffeine exposure [5,20]. Peck et al. con-
cluded in their review that the evidence for an association
between caffeine intake and reproductive health and fetal
development is limited by measurement errors as well as
by the impossibility of ruling out confounding by preg-
nancy symptoms such as nausea or environmental factors
such as smoking. Caffeine consumption is strongly corre-
lated with smoking, which is known to increase the risk
for both PTD and SGA. As mentioned above, there are
methodological challenges in the assessment of caffeine
intake, both from coffee and other sources. This also
applies to preparation and processing, which may change
the caffeine content of a beverage considerably. Preg-
nancy is a time of rapid development and differentiation,
therefore there might be a certain time window for a caf-
feine effect; repeated measurements during pregnancy
may thus be desirable [20].
In summary, caffeine is consumed daily by many preg-
nant women, spontaneous PTD and SGA incur high medi-
cal and economic costs and studies on associations
between caffeine and pregnancy outcomes are contradic-
tory due to a number of challenges in study design. The
Norwegian Mother and Child Cohort Study (MoBa) can
meet many of these challenges: with about 108,000
included pregnancies, common complex pregnancy out-
comes like PTD and SGA can be studied. With detailed
reporting of caffeine intake from various sources and dif-
ferent coffee preparations, assessed at three different time-
points during pregnancy, as well as comprehensive
information on lifestyle habits, health and socioeconomic
status, MoBa provides a unique chance to study the asso-
ciation between caffeine intake and pregnancy outcomes.
By taking caffeine intake from different sources into
account, it might be possible to separate caffeine effects
from other effects related to the respective sources.
The aim of the present study therefore was to examine
the association between maternal caffeine intake from dif-
ferent sources and (a) gestational length, particularly the
risk for spontaneous PTD with a subanalysis of early and
late spontaneous PTD, and (b) BW and the risk for SGA.
Methods
Study population
The dataset is part of the MoBa cohort, initiated by and
maintained at the Norwegian Institute of Public Health
[28]. In brief, MoBa is a nationwide pregnancy cohort,
including more than 108,000 pregnancies during the
period 1999 to 2009. Women were recruited by postal
invitation in connection with the routine ultrasound
examination offered to all pregnant women in Norway
at around 17 gestational weeks. Overall, 38.5% of invited
women have participated. Participants were asked to fill
in questionnaires focused on general health status, life-
style behavior and diet at gestational weeks 15 to 17
(Q1) and 30 (Q3). At gestational week 22, they com-
pleted a food frequency questionnaire (FFQ). All ques-
tionnaires are available on the Norwegian Institute of
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Public Health homepage [33]. This study used data from
version 5 of the quality-assured data files made available
for research in 2010. Pregnancy and birth records from
the Medical Birth Registry of Norway (MBRN) are
linked to the MoBa database [34]. Informed written con-
sent was obtained from each participant. The Regional
Committee for Medical Research and the Norwegian
Data Inspectorate approved the study.
Of the 106,707 pregnancies included in MoBa version
5, 103,835 women gave birth to live-born singletons;
81,301 of these women had answered all three question-
naires. After exclusion of the following medical and preg-
nancy-related conditions 70,105 pregnancies remained in
the study: diabetes mellitus, hypertension, autoimmune
disease, inflammatory bowel disease, systemic lupus
erythematosus, rheumatoid arthritis, scleroderma, other
immune-compromised conditions, in vitro fertilization,
pre-eclampsia, hypertension, gestational diabetes, placen-
tal abruption, placenta previa, cervical cerclage and ser-
ious fetal malformations. Women reporting improbable
energy intake, that is, <4.5 MJ or >20 MJ, were excluded
[35], leaving 69,045 pregnancies. If a woman participated
with more than one pregnancy, only the first pregnancy
was included, leaving 60,496. Finally, 59,123 women had
complete data on pre-pregnancy weight and height.
Outcome
Gestational age in days was determined by second-trime-
ster ultrasound in 98.3% of pregnancies and based on the
last menstrual period in the remaining cases. The expected
effect of caffeine on gestational length is minor; results are
thus presented in hours instead of days. Spontaneous PTD
was defined as birth after preterm labor or prelabor rup-
ture of the membranes between 22+0 to 36+6 weeks, while
controls delivered spontaneously between 39+0 to 40+6
weeks. A subanalysis was conducted for the subgroups
early (22+0 to 33+6 weeks) and late (34+0 to 36+6 weeks)
spontaneous PTD.
BW in grams was registered in the MBRN. As there is
still no consensus on standard growth curves, data were
analyzed according to three standards based on Northern
European populations: ultrasound-based growth curves
according to Marsal [36], population-based growth curves
according to Skjaerven [37] and customized growth curves
according to Gardosi [38].
The difference between BW and expected BW was cal-
culated as a percentage of expected BW. This implicates
that gestational length is taken into account by the defi-
nition of our outcome variable and analysis were not
adjusted for gestational age. Percentage was used instead
of the difference in g, as a slight weight difference matters
much more if the expected BW for a preterm infant is
very low compared with a normal-weight infant born at
term. While the original outcome of the linear regression
thus was a percentage of the expected BW, we chose to
present the results in g for babies with an expected BW
of 3,600 g, the rounded-out median BW in our study
population (actual median: 3,620 g). SGA was defined
according to the above-mentioned authors’ respective
definitions: less than-2 SD (Marsal) or <tenth percentile
(Skjaerven, Gardosi). Standard deviation and percentiles
used are based on the reference population in these pub-
lications, not on our study population, which is a highly
selected subpopulation of the MoBa population, as
described above.
Caffeine intake
The MoBa FFQ is a semiquantitative questionnaire
designed to record dietary habits and intake of dietary sup-
plements during the first four to five months of pregnancy.
Women reported their beverage consumption in cups per
day, week or month. Coffee was specified as either filtered,
instant, boiled/pressed, decaffeinated, caffè latte/cappuc-
cino, espresso or fig/barley coffee. One cup was defined as
125 ml. In the case of black tea, one cup was defined as
250 ml. One glass of sugar-sweetened or diet cola, energy
drink or chocolate milk was defined as 250 ml. Other caf-
feine sources reported were sandwich spread, desserts,
cakes and sweets containing cocoa [33]. Caffeine and
nutrient calculations were performed using FoodCalc [39]
and the Norwegian Food Composition Table [40]. For the
purpose of this analysis, we compiled a caffeine database
presenting the caffeine concentration in the main food
and beverage items, depending on manner of preparation
in the case of coffee, contributing to caffeine intake in the
Norwegian diet (Table 1). Information about caffeine con-
centrations in coffee, tea and cocoa was obtained from
published reports [5,41]. Caffeine concentration in soft
and energy drinks was based on both figures from pub-
lished reports [41] and the brewing industry. Coffee
houses offered information on the content of coffee in dif-
ferent coffee drinks. The amount of caffeine in cocoa con-
taining food items like chocolate was calculated based on
data provided by the chocolate and food industry. The
FFQ has been extensively validated in a MoBa subpopula-
tion (n = 119) using a four-day weighed food diary and
biological markers in blood and urine as reference mea-
sures [42,43]. The validation study showed that the MoBa
FFQ is a valid instrument for assessing habitual diet during
the first four to five months of pregnancy. The agreement
between the FFQ and the food diary was particularly high
for coffee (r = 0.80, 95% CI 0.72 to 0.86), and was high for
tea (r = 0.53, 95% CI 0.39 to 0.65) and soft drinks (r =
0.48, 95% CI 0.33 to 0.61). Estimated caffeine intake was
not evaluated at the time, but when caffeine concentra-
tions (Table 1) were combined with consumption data for
women in the validation study, high agreement was
observed between the FFQ and the food dairy for total
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caffeine (r = 0.70, 95% CI 0.59 to 0.78). The median (IQR)
caffeine intake in the validation study sample was 40 mg/
day (18 to 88 mg/day) by the FFQ and 38 mg/day (10 to
99 mg/day) by the food diary. Caffeine from coffee and tea
showed similar high agreement as for the beverages, while
poorer agreement was seen for caffeine from chocolate
(r = 0.20, 95% CI 0.02 to 0.36). No participants in the vali-
dation study had intake of caffeine from soft drinks. Food
items like soft drinks, chocolate and sweets are more likely
to be misreported than most other food items.
In Q1 and Q3, women reported their coffee, tea and caf-
feinated soft drink consumption in cups or glasses/day.
These data allowed following a participant’s caffeine con-
sumption from the three main caffeine sources from the
time before pregnancy until gestational week 30. Caffeine
intake was entered into the analysis in mg/day, adjusted to
a woman’s pre-pregnancy weight and recalculated as if
every woman weighed 65 kg (median pre-pregnancy
weight in the study population): 65 kg × caffeine intake/
pre-pregnancy weight [44].
All analyses were based on the more detailed FFQ caf-
feine intake data, except when the association between caf-
feine intake and pregnancy outcomes at different
timepoints was studied using Q1 and Q3 data.
Covariates
Information on maternal age at delivery and the baby’s
sex was available from the MBRN. Parity was based on
both MoBa and MBRN data and categorized into number
of previous pregnancies of ≥22+0 weeks’ duration. Marital
status was defined as either married/cohabiting or not.
Self-reported pre-pregnancy height and weight were used
to calculate pre-pregnancy body mass index (BMI),
which was categorized according to the WHO classifica-
tion as underweight (<18.5 kg/m2), normal weight (18.5
to 24.9 kg/m2), overweight (25 to 29.9 kg/m2) and obese
(≥30 kg/m2). Maternal education was categorized as ≤12
years, 13 to 16 years or ≥17 years. History of previous
PTD (22+0 to 36+6 weeks of gestation), as registered in
the MBRN, was taken into account as a dichotomous
variable. Women reported smoking habits during preg-
nancy in Q1 and were categorized as non-smokers, occa-
sional or daily smokers. Passive smoking and use of other
nicotine sources were considered to be dichotomous
variables. Alcohol intake from different sources was self-
reported in the FFQ (glasses/day, week or month) and
calculated in g/day. Persistent nausea at the time of
answering the FFQ was used as a dichotomous variable.
Household income was categorized as follows: participant
and her partner each earning <300,000 Norwegian
Krones (NOK)/year, either participant or her partner
earning ≥300,000 NOK/year or participant and her part-
ner both earning ≥300,000 NOK/year. In MoBa, more
than 99% of the participants are of Caucasian ethnicity;
hence ethnicity is not a relevant confounder.
Statistics
All statistical analyses were performed using SPSS Sta-
tistics V.19.0 (SPSS, Chicago, IL, USA). Caffeine intake
in relation to maternal characteristics was studied with
the Kruskal-Wallis test. Associations between caffeine
intake and gestational length and BW were studied with
linear regression both in an unadjusted model and
adjusted for the covariates mentioned above. We visually
inspected residual plots to check if model assumptions
were reasonably fulfilled. Odds ratios (OR) for caffeine
Table 1 Caffeine content in different food items
Food item Caffeine (mg)/100 g
Coffee, filtered and percolated/pressed 57
Powdered instant coffee 40
Espresso 114
Cappuccino and caffè latte 21
Decaffeinated coffee 2
Caffeinated soft drinks, sugar sweetened and artificially sweeteneda 12
Energy drinks 15b
Black tea 16
Chocolate milk 2
Sandwich spread containing cocoa 13
Dessert containing cocoa 3
Cake containing cocoa 4
Chocolate, medium-dark 38
Milk chocolate 15
Sweets containing cocoa 9
Caffeine content in food items included in the database used for estimating caffeine intake in the Norwegian Mother and Child Cohort Study 2002 to 2009.
aCaffeinated soft drinks included in the food frequency questionnaire: Coca Cola/Pepsi with sugar, Coca Cola light, Pepsi Light.
bMaximum caffeine content in energy drinks in Norway until 2009.
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intake and categorical outcome variables were estimated
using logistic regression, both unadjusted and adjusted,
as above. Statistical significance was assumed for a two-
sided P value <0.05. Subanalyses were performed in the
subgroups of non-smokers and non-coffee drinkers.
Results
Figure 1 shows the distribution of total caffeine intake as
registered in the FFQ. Coffee, black tea, soft drinks and
chocolate accounted for more than 98% of daily caffeine
intake but, interestingly, the dominant source differed in
the low-intake and high-intake groups, with chocolate
dominating in the first quintile, black tea in the second
and third quintiles and coffee in the upper quintiles
(Figure 2). Self-reported pre-pregnancy caffeine intake
from coffee, black tea and soft drinks in Q1 and
Q3 revealed a median intake of 126 mg/day (IQR 40 to
254 mg/day) for all 59,123 women, including 7,406
women who did not consume any caffeine at all. At
gestational week 17 the number of non-consumers was
nearly doubled (14,012 women) and the median caffeine
intake had decreased to 44 mg/day (13 to 104 mg/day).
At gestational week 30, the median caffeine intake had
increased again to 62 mg/day (21 to 130 mg/day)
and 9,792 women remained non-consumers. Caffeine
intake related to maternal characteristics is presented in
Table 2: older, unmarried and smoking women with
higher parity, history of PTD, lower pre-pregnancy BMI,
less nausea, higher energy intake and higher household
income had significantly higher caffeine intake.
Gestational length and spontaneous PTD
A total of 49,102 women delivered spontaneously with a
median gestational length of 282 days (IQR 276 to 287
days). Gestational length as well as its residuals were left
skewed, but we preferred to use the original data scale for
easier interpretation.
Caffeine intake from different sources (FFQ data)
Total caffeine intake was associated with slightly
increased gestational length, that is, 5 h/100 mg/day (95%
CI 3 to 8 h, P <10-4) (Table 3). However, linear regression
with all different caffeine sources included in the same
model revealed that only coffee caffeine was significantly
Figure 1 Percentage of total caffeine intake per caffeine source. This figure shows the percentage of total caffeine intake per caffeine
source (food frequency questionnaire data), n = 59,123, in the Norwegian Mother and Child Cohort Study 2002 to 2009.
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associated with gestational length. When the different
caffeine sources were studied individually, it emerged
that the association for total caffeine intake resembled
that for coffee caffeine intake (8 h/100 mg coffee caf-
feine/day, 95% CI 5 to 10 h, P <10-7). If all sources were
studied individually without mutual adjustment, only cof-
fee caffeine remained significantly associated with gesta-
tional length (8 h/100 mg coffee caffeine/day; 95% CI 5
to 10 h, P <10-6). As we found that coffee is the dominant
source of caffeine in high-caffeine consumers, these find-
ings could be explained by a threshold model implying
that only coffee drinkers reach the threshold associated
with altered gestational length. To rule out this possibi-
lity, we compared the coffee caffeine intake categorized
into five groups (no intake and for the remaining subjects
quartiles 0 to 8.38, 8.39 to 40.71, 40.72 to 110.52, >110.52
mg/day) finding that compared to the fifth group even
group one and two had a significantly shorter gestational
length (first group: regression coefficient b = -3.2, P =
0.04, second group: b = -4.2, P = 0.02). After excluding
all coffee consumers from the analysis, black tea and cho-
colate were still not associated with gestational length
while caffeinated soft drinks were associated with a 13 h
decreased gestational length/100 mg additional caffeine/
day (95% CI 1 to 24 h, P = 0.032) in the remaining 17,491
women. In the subgroup of non-coffee consumers, total
caffeine intake was significantly associated with 10 h
decreased gestational length/100 mg additional caffeine/
day (95% CI 1 to 18 h, P = 0.017, adjusted models). When
performing the linear regression in only non-smokers (n =
45,053), coffee caffeine was still the only caffeine source
significantly associated with gestational length (total caf-
feine intake 7 h/100 mg caffeine/day, 95% CI 4 to 10 h,
P <10-5, coffee caffeine 10 h/100 mg caffeine/day, 95% CI
7 to 13 h, P <10-9, adjusted models).
There were 1,451 cases of spontaneous PTD in the study
population (240 early spontaneous PTDs and 1,211 late
spontaneous PTDs), compared to 27,498 controls, accord-
ing to our strict inclusion and exclusion criteria. There
was no significant association between total or coffee caf-
feine intake and the odds for overall, early or late sponta-
neous PTD (Table 4). Black tea caffeine was associated
with increased risk of early spontaneous PTD (OR 1.61,
95% CI 1.10 to 2.35, P = 0.01, adjusted model).
Caffeine intake over time (Q1 and Q3 data)
At all timepoints studied, total and coffee caffeine intake
was consistently associated with increased gestational
length. The association was strongest for caffeine con-
sumption reported at gestational week 17 (3 h/100 mg
total caffeine/day, 95% CI 1 to 4 h; 4 h/100 mg coffee caf-
feine/day, 95% CI 2 to 5 h, both P <0.001), followed by that
reported at gestational week 30 (2 h/100 mg total caffeine/
day, 95% CI 0 to 3 h, P = 0.02; 3 h/100 mg coffee caffeine/
day, 95% CI 1 to 5 h, P <0.001) and reported pre-pregnancy
caffeine consumption (2 h/100 mg total caffeine/day, 95%
CI 1 to 3 h; 2 h/100 mg coffee caffeine/day, 95% CI 1 to
3 h, both P <10-6); all adjusted models.
Birth weight and SGA
The diagnosis of SGA varied considerably depending on
the growth curve and SGA definition applied (Figure 3).
Figure 2 Sources of caffeine intake according to quintiles of total caffeine intake. This figure shows sources of caffeine intake (food
frequency questionnaire data) according to quintiles of total caffeine intake, n = 59,123, in the Norwegian Mother and Child Cohort Study 2002
to 2009.
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Table 2 Caffeine intake according to maternal characteristics
Characteristic Category n % Total caffeine, mg/day Coffee caffeine, mg/day Tea caffeine, mg/day
Median (IQR) P valuea Median (IQR) P valuea Median (IQR) P valuea
Total - 59,123 100 57 (23 to 121) - 7 (0 to 69) - 5 (1 to 29) -
Maternal age, years <25 6,688 11 34 (15 to 81) 0 (0 to 14) 3 (0 to 15)
25 to 29 20,354 34 47 (19 to 102) <10-246 5 (0 to 46) <10-246 5 (1 to 22) <10-246
30 to 34 25,213 43 68 (27 to 134) 11 (0 to 83) 6 (1 to 34)
>34 6,868 12 91 (39 to 171) 30 (1 to 124) 7 (2 to 38)
Parity 0 30,393 51 47 (19 to 103) 6 (0 to 49) 5 (1 to 23)
1 18,686 32 66 (26 to 133) <10-92 8 (0 to 81) <10-92 6 (1 to 32) <10-36
2 8,135 14 82 (31 to 163) 12 (0 to 101) 6 (1 to 35)
≥3 1,873 3 94 (34 to 181) 17 (0 to 138) 5 (0 to 34)
Missing 36 0.1 58 (22 to 142) - 8 (0 to 98) - 7 (0 to 30) -
Marital statusb Yes 56,941 96 57 (23 to 120) 0.004 7 (0 to 69) 0.89 5 (1 to 29) <10-13
No 2,182 4 60 (21 to 146) 6 (0 to 79) 3 (0 to 20)
Pre-pregnancy BMI, kg/m2 <18.5 1,835 3 69 (27 to 145) 8 (0 to 81) 7 (2 to 37)
18.5 to 24.9 39,834 67 62 (25 to 129) <10-183 9 (0 to 79) <10-119 6 (1 to 33) <10-237
25 to 29.9 12,444 21 51 (20 to 107) 5 (0 to 58) 5 (1 to 24)
≥30 5,01 8 39 (14 to 84) 2 (0 to 32) 2 (0 to 13)
Maternal education, years ≤12 17,925 30 55 (21 to 128) 4 (0 to 66) 3 (0 to 19)
13 to 16 24,782 42 54 (22 to 114) <10-34 7 (0 to 64) <10-124 6 (1 to 29) <10-276
≥17 15,201 26 65 (27 to 125) 14 (0 to 79) 7 (2 to 37)
Missing 1,215 2 60 (22 to 124) - 7 (0 to 69) - 5 (0 to 28) -
History of preterm delivery No 57,121 97 57 (22 to 121) <10-6 7 (0 to 68) 0.91 5 (1 to 29) 0.29
Yes 1,928 3 69 (25 to 141) 7 (0 to 80) 6 (1 to 32)
Missing 74 0.1 47 (19 to 102) - 12 (0 to 84) - 5 (1 to 22) -
Smoking habits Never 54,136 92 54 (21 to 113) 7 (0 to 61) 6 (1 to 30)
Occasionally 1,569 3 109 (42 to 201) <10-226 44 (0 to 163) <10-226 3 (0 to 21) <10-101
Daily 3,085 5 143 (57 to 260) 70 (0 to 198) 2 (0 to 14)
Missing 333 1 69 (24 to 127) - 10 (0 to 79) - 6 (0 to 34) -
Passive smoking No 51,931 88 56 (22 to 118) <10-24 7 (0 to 67) 0.08 6 (1 to 30) <10-53
Yes 6,082 10 66 (24 to 153) 7 (0 to 86) 3 (0 to 19)
Missing 1,11 2 61 (22 to 139) - 7 (0 to 84) - 5 (0 to 26) -
Nicotine other than cigarettes No 58,552 99 57 (22 to 120) <10-52 7 (0 to 68) <10-49 5 (1 to 29) 0.06
Yes 571 1 138 (57 to 221) 89 (4 to 178) 4 (0 to 27)
Alcohol consumption, units/week No alcohol 52,47 89 53 (21 to 114) 6 (0 to 60) 5 (1 to 28)
<0.5 5,579 9 93 (44 to 168) <10-90 39 (4 to 118) <10-90 8 (2 to 37) <10-90
≥0.5 1,074 2 126 (67 to 216) 73 (13 to 173) 15 (2 to 39)
Nausea during second trimester No 52,567 89 59 (24 to 125) <10-83 8 (0 to 74) <10-167 5 (1 to 29) <10-10
Yes 6,556 11 43 (16 to 97) 0 (0 to 21) 4 (0 to 28)
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Table 2 Caffeine intake according to maternal characteristics (Continued)
Partners with income of >300,000 NOK/year 0 16,327 28 49 (19 to 113) 4 (0 to 54) 4 (0 to 24)
1 24,483 41 56 (22 to 120) <10-72 6 (0 to 66) <10-152 5 (1 to 28) <10-81
2 16,746 28 68 (28 to 129) 14 (0 to 83) 6 (2 to 34)
Missing 1,567 3 57 (21 to 131) - 5 (0 to 65) - 4 (0 to 24) -
Baby’s sex Male 30,049 51 58 (23 to 122) 0.13 7 (0 to 70) 0.7 5 (1 to 29) 0.62
Female 29,074 49 57 (22 to 120) 7 (0 to 68) 5 (1 to 29)
Quartiles of energy intake, MJ <7.90 14,781 25 42 (15 to 96) 4 (0 to 46) 3 (0 to 21)
7.90 to 9.35 14,78 25 53 (21 to 112) <10-72 7 (0 to 66) <10-75 5 (1 to 28) <10-99
9.36 to 11.14 14,782 25 61 (25 to 126) 8 (0 to 73) 6 (1 to 31)
>11.14 14,78 25 78 (32 to 158) 10 (0 to 89) 6 (1 to 44)
Caffeine intake (food frequency questionnaire data) according to maternal characteristics, n = 59,123, in the Norwegian Mother and Child Cohort Study 2002 to 2009.
aP value for being sampled from the same distribution (Kruskal-Wallis test).
cMarital status was defined as either married/cohabiting or not.
BMI = body mass index.
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Caffeine intake from different sources (FFQ data)
Total caffeine intake, as well as caffeine intake from the
individual sources, was associated with lower BW (Table 5).
The dependent variable in the linear regression was the
difference between reported actual BW and expected BW,
calculated as percentage of the expected BW. For easier
understanding and interpretation, results are presented as a
change in BW per 100 mg additional caffeine/day for a
child with an expected BW of 3,600 g, the rounded-out
median of BW in our study population (median 3,620 g). In
the adjusted model, intake of an additional 100 mg total
caffeine/day was associated with a 21 to 28 g BW decrease,
depending on the growth curve. The opposite effect of cho-
colate caffeine in the Gardosi model was no longer signifi-
cant after adjustment.
When studied exclusively in non-smokers (n = 54,136),
these associations remained significant, again with the
exception of chocolate caffeine in the Gardosi model.
However, the decrease in BW was somewhat lower:
Marsal 18 g (95% CI 15 to 21 g) instead of 28 g, Skjaerven
15 g (95% CI 12 to 18 g) instead of 25 g, Gardosi 12 g
(95% CI 9 to 15 g) instead of 21 g per 100 mg additional
total caffeine/day (all significant with P <10-15; adjusted
models).
Total and coffee caffeine intake was significantly asso-
ciated with higher odds for SGA, based on logistic regres-
sion in all three SGA models, both unadjusted and adjusted
(Table 6). Energy drink and black tea caffeine intake were
associated with a significant increase in two of the three
SGA models, while there was no significant association
with chocolate caffeine. The association of total caffeine
intake and BW remained significant when analyses were
limited to the non-smoker subgroup (n = 54,136).
To test if there was a threshold effect, we performed the
same logistic regression with sextiles of total caffeine intake
(0 to 14.645, 14.646 to 32.093, 32.094 to 57.265, 57.266 to
96.029, 9603 to 163.806, >163.806 mg/day). In all three
models the caffeine intake categories were associated with
increasing odds ratios for SGA as compared to the lowest
intake group (see Figure 4). According to FFQ data, 10.8%
of all women exceeded the NNR recommendation of less
than 200 mg/day caffeine intake during pregnancy and
Table 3 Gestational length in pregnancies with spontaneous delivery and caffeine intake from different sources
Caffeine source Unadjusted Adjusted
b (h) 95% CI P valuea b (h) 95% CI P valuea
Total 4 2 to 7 <10-4 5 3 to 8 <10-4
Coffee, all types 8 5 to 10 <10-8 8 5 to 10 <10-7
Caffeinated soft drinksb -14 -22 to-6 <10-3 -8 -16 to 1 0.07
Black tea 0 -7 to 7 0.9 -1 -8 to 6 0.8
Chocolate -42 -77 to-7 0.02 -11 -49 to 26 0.5
Gestational length in pregnancies with spontaneous delivery and caffeine intake from different sources (food frequency questionnaire (FFQ) data), linear
regression for four caffeine sources as well as total caffeine intake, n = 49,102, in the Norwegian Mother and Child Cohort Study 2002 to 2009. b = change in
gestational length (h) per 100 mg additional caffeine/day.
aP value, linear regression. Adjustment for maternal age, pre-pregnancy body mass index, parity, history of preterm delivery, baby’s sex, nausea during second
trimester, smoking habits, passive smoking, nicotine intake from other sources, alcohol consumption during pregnancy, energy intake, maternal education,
marital status and household income. In the analysis of the separate caffeine sources, these were mutually adjusted (coffee, caffeinated soft drinks, black tea and
chocolate).
bCaffeinated soft drinks included in the FFQ: Coca Cola/Pepsi with sugar, Coca Cola light, Pepsi Light.
Table 4 Odds for spontaneous preterm delivery (PTD) and caffeine intake from different sources
Caffeine source All PTD (22+0 to 36+6 weeks) Early PTD (22+0 to 33+6 weeks) Late PTD (34+0 to 36+6 weeks)
ORa 95% CI P valueb ORa 95% CI P valueb ORa 95% CI P valueb
Total 0.98 0.92 to 1.05 0.6 0.96 0.81 to 1.14 0.7 0.99 0.92 to 1.06 0.7
Coffee, all types 0.96 0.89 to 1.04 0.3 0.82 0.66 to 1.02 0.08 0.98 0.91 to 1.07 0.7
Caffeinated soft drinksc 1.10 0.90 to 1.34 0.4 1.21 0.77 to 1.89 0.4 1.07 0.87 to 1.33 0.5
Black tea 0.99 0.82 to 1.20 0.9 1.61 1.10 to 2.35 0.01 0.89 0.71 to 1.11 0.3
Chocolate 1.43 0.55 to 3.67 0.5 1.08 0.10 to 12.06 0.9 1.51 0.55 to 4.15 0.4
Odds ratios for spontaneous PTD, as well as for early (n = 240) and late (n = 1,211) spontaneous PTD subgroups, and caffeine intake from different sources (food
frequency questionnaire (FFQ) data), logistic regression for four caffeine sources as well as total caffeine, n = 28,949, in the Norwegian Mother and Child Cohort
Study 2002 to 2009.
aOR: odds ratio for spontaneous PTD groups, compared to a strictly defined control group with spontaneous delivery at weeks 39+0 to 40+6, per 100 mg
additional caffeine/day.
bP value, logistic regression. Adjustment for maternal age, pre-pregnancy body mass index, parity, history of PTD, baby’s sex, nausea during second trimester,
smoking habits, passive smoking, nicotine intake from other sources, alcohol consumption during pregnancy, energy intake, maternal education, marital status
and household income. In the analysis of the separate caffeine sources, these were mutually adjusted (coffee, caffeinated soft drinks, black tea and chocolate).
cCaffeinated soft drinks included in the FFQ: Coca Cola/Pepsi with sugar, Coca Cola light, Pepsi Light.
Sengpiel et al. BMC Medicine 2013, 11:42
http://www.biomedcentral.com/1741-7015/11/42
Page 9 of 18
3.3% also exceeded the WHO recommendation of less than
300 mg/day. If the odds for SGA were studied with refer-
ence to these recommendations, those 7.7% of women
with a daily caffeine intake of 200 to 300 mg had signifi-
cantly higher odds for SGA (1.27 to 1.62, depending on
the SGA definition), in comparison with the lowest (0 to
50 mg/day) caffeine intake group. The odds of giving birth
to a SGA infant were 1.62 to 1.66 in the 3.3% of women
consuming >300 mg caffeine/day (Table 7).
Caffeine intake over time (Q1 and Q3 data)
Total and coffee caffeine intake at all timepoints studied
was significantly associated with decreased BW for all
applied SGA models. The association with caffeine intake
from black tea was the strongest with the Skjaerven and
Marsal models. Tea caffeine was not significantly asso-
ciated with BW if defined according to Gardosi, though.
For caffeine from coffee and soft drinks, intake reported
at gestational week 17 had the strongest impact on BW
(Table 8).
Discussion
Caffeine from coffee, but not from other sources, was
associated with slightly increased gestational length. Total
caffeine and caffeine from all different sources studied was
associated with decreased BW. When discussing these
results, the caffeine intake pattern in this Norwegian sub-
population must be kept in mind: the dominant caffeine
source varied with increasing total caffeine intake, from
chocolate in the low consumption group, to black tea in
Figure 3 Overlap of small for gestational age (SGA) definitions according to Marsal (ultrasound based), Skjaerven (population based)
and Gardosi (customized), n = 59,123, in the Norwegian Mother and Child Cohort Study 2002 to 2009.
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the medium consumption group, and coffee in the high
consumption group. Thus, findings attributed to increas-
ing total caffeine intake might be due to a changing distri-
bution of caffeine sources. These results emphasize what
Peck et al. and the CARE Study Group pointed out: if the
aim of an epidemiologic study is to assess the effect of caf-
feine, it is not correct to study only coffee caffeine [20,45].
Many, but not all, women decreased their caffeine
consumption considerably during the first trimester but
increased it again during the second trimester, a motive
for repeated caffeine intake measurements during preg-
nancy in studies examining exposure in relation to preg-
nancy outcome [20,45].
Gestational length and spontaneous PTD
We found that total and coffee caffeine intake was
associated with a highly significant increase of gesta-
tional length by 5 and 8 hours/100 mg respectively.
Table 5 Birth weight and caffeine intake from different sources
Caffeine source Birth weight (Marsal) Birth weight (Skjaerven) Birth weight (Gardosi)
b (g) 95% CI P valuea b (g) 95% CI P valuea b (g) 95% CI P valuea
Unadjusted:
Total -28 -32 to-25 <10-48 -27 -31 to-23 <10-44 -12 -16 to-9 <10-10
Coffee, all types -25 -29 to-21 <10-30 -22 -26 to-18 <10-24 -15 -19 to-11 <10-12
Caffeinated soft drinksb -11 -24 to 1 0.08 -19 -32 to-6 0.005 -18 -30 to-5 0.006
Black tea -53 -65 to-41 <10-18 -53 -65 to-42 <10-18 -3 -15 to 8 0.5
Chocolate -164 -222 to-106 <10-7 -196 -254 to-138 <10-10 159 103 to 215 <10-7
Adjusted:
Total -28 -32 to-24 <10-43 -25 -29 to-21 <10-34 -21 -24 to-17 <10-25
Coffee, all types -24 -28 to-19 <10-26 -20 -24 to-15 <10-18 -19 -24 to-15 <10-19
Caffeinated soft drinksb -34 -47 to-22 <10-7 -38 -50 to-25 <10-8 -23 -35 to-11 <3 × 10-4
Black tea -50 -61 to-39 <10-17 -48 -59 to-36 <10-15 -29 -40 to-18 <10-6
Chocolate -129 -188 to-70 <10-4 -133 -192 to-73 <10-4 -4 -62 to 53 0.9
Birth weight (BW) and caffeine intake from different sources (food frequency questionnaire (FFQ) data), linear regression for four caffeine sources as well as total
caffeine intake, n = 59,123 in the Norwegian Mother and Child Cohort Study, 2002 to 2009. b = BW decrease or increase in g per 100 mg additional caffeine/day for a
baby with an expected BW of 3,600 g. Expected BW defined according to Marsal (ultrasound based), Skjaerven (population based) or Gardosi (customized).
aP value, linear regression. Adjustment for maternal age, pre-pregnancy body mass index, parity, history of preterm delivery, baby’s sex, nausea during second
trimester, smoking habits, passive smoking, nicotine intake from other sources, alcohol consumption during pregnancy, energy intake, maternal education, marital
status, household income. In the analysis of the separate caffeine sources, these were mutually adjusted (coffee, caffeinated soft drinks, black tea and chocolate).
bCaffeinated soft drinks included in the FFQ: Coca Cola/Pepsi with sugar, Coca Cola light, Pepsi Light.
Table 6 Odds for small for gestational age (SGA) and caffeine intake from different sources
Caffeine source SGA (Marsal) SGA (Skjaerven) SGA (Gardosi)
ORa 95% CI P valueb ORa 95% CI P valueb ORa 95% CI P valueb
Unadjusted:
Total 1.24 1.16 to 1.31 <10-11 1.17 1.13 to 1.20 <10-24 1.07 1.04 to 1.11 <10-4
Coffee, all types 1.21 1.13 to 1.30 <10-7 1.16 1.12 to 1.20 <10-17 1.10 1.06 to 1.13 <10-7
Caffeinated soft drinksc 1.35 1.09 to 1.67 0.007 1.27 1.14 to 1.41 <10-5 1.25 1.13 to 1.39 <10-4
Black tea 1.42 1.16 to 1.73 <10-3 1.20 1.09 to 1.33 <10-3 0.92 0.82 to 1.02 0.1
Chocolate 0.89 0.28 to 2.83 0.8 1.04 0.62 to 1.75 0.9 0.16 0.09 to 0.28 <10-9
Adjusted:
Total 1.18 1.10 to 1.26 <10-5 1.15 1.11 to 1.19 <10-15 1.11 1.08 to 1.15 <10-9
Coffee, all types 1.14 1.06 to 1.23 <10-3 1.13 1.09 to 1.17 <10-10 1.11 1.07 to 1.16 <10-7
Caffeinated soft drinksc 1.22 0.97 to 1.53 0.08 1.29 1.16 to 1.43 <10-5 1.19 1.06 to 1.33 0.002
Black tea 1.50 1.22 to 1.83 <10-4 1.21 1.09 to 1.34 <10-3 1.11 0.99 to 1.23 0.06
Chocolate 1.07 0.32 to 3.54 0.9 1.06 0.61 to 1.84 0.8 0.62 0.34 to 1.12 0.1
Odds for SGA and caffeine intake from different sources (food frequency questionnaire (FFQ) data), logistic regression for four caffeine sources as well as total
caffeine intake, n = 59,123 in the Norwegian Mother and Child Cohort Study, 2002 to 2009. SGA definition based on growth curves according to Marsal
(ultrasound based), Skjaerven (population based) or Gardosi (customized).
aOR: odds ratio, compared to non-SGA, per 100 mg additional caffeine intake/day.
bP value, logistic regression. Adjustment for maternal age, pre-pregnancy body mass index, parity, history of preterm delivery, baby’s sex, nausea during second
trimester, smoking habits, passive smoking, nicotine intake from other sources, alcohol consumption during pregnancy, energy intake, maternal education, marital
status and household income. In the analysis of the separate caffeine sources, these were mutually adjusted (coffee, caffeinated soft drinks, black tea and chocolate).
cCaffeinated soft drinks included in the FFQ: Coca Cola/Pepsi with sugar, Coca Cola light, Pepsi Light.
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The corresponding association with total caffeine
intake was, conversely, 10 hours decreased gestational
length, though only marginally significant, when coffee
drinkers were excluded from the model. Additionally,
we ruled out a threshold effect, as even the groups
with the lowest coffee caffeine intake were significantly
associated with gestational length. Our results do not
support the hypothesis that caffeine intake influences
the risk for spontaneous PTD. The only marginally sig-
nificant finding was black tea caffeine being associated
with higher PTD odds, in the relatively small subgroup
of early spontaneous PTD. We therefore conclude that
the association of total caffeine intake with gestational
length is not related to caffeine but to coffee intake.
This study was not designed to disclose the reason for this
statistical association; one possible explanation is that
there might be some other substance, present in coffee
but not in the other caffeine sources, that influences gesta-
tional length. Human parturition is depending on a phy-
siological inflammatory reaction leading to cervical
ripening and increased uterus tonus [46]. Melanoidins that
are generated from coffee bean components during the
roasting process are, for example, known to have antimi-
crobial and anti-inflammatory effects [47] and thus might
influence the timing of parturition. People in Scandinavia
who do not drink coffee constitute a definite minority and
those with a very low caffeine intake are probably a special
group in many other ways. Drinking coffee, but not
Figure 4 Small for gestational age (SGA) risk depending on total caffeine intake. Relative risk for SGA in sextiles of total caffeine intake
with the lowest sextile as reference category (0 to 14.645, 14.646 to 32.093, 32.094 to 57.265, 57.266 to 96.029, 9603 to 163.806, >163.806 mg/
day). SGA definitions according to Marsal (ultrasound based), Skjaerven (population based) and Gardosi (customized), n = 59,123, in the
Norwegian Mother and Child Cohort Study 2002 to 2009. Adjustment for maternal age, pre-pregnancy body mass index, parity, history of
preterm delivery, baby’s sex, nausea during second trimester, smoking habits, passive smoking, nicotine intake from other sources, alcohol
consumption during pregnancy, energy intake, maternal education, marital status and household income.
Table 7 Odds for small for gestational age (SGA) and total caffeine intake according to official guidelines
Total caffeine intake
groups (mg/day)
Number of individuals SGA (Marsal) SGA (Skjaerven) SGA (Gardosi)
ORa 95% CI P valueb ORa 95% CI P valueb ORa 95% CI P valueb
0 to 50 27,000 1 1 1
51 to 200 25,718 1.18 1.00 to 1.38 0.04 1.12 1.05 to 1.21 0.001 1.09 1.02 to 1.17 0.01
201 to 300 4,447 1.62 1.26 to 2.09 <10-3 1.44 1.28 to 1.62 <10-8 1.27 1.12 to 1.44 <10-3
>300 1,958 1.62 1.15 to 2.29 0.006 1.66 1.41 to 1.96 <10-8 1.62 1.36 to 1.92 <10-7
Odds ratios for SGA and total caffeine intake (food frequency questionnaire (FFQ) data), according to official Nordic Nutrition Recommendations (<200 mg
caffeine/day) and World Health Organization (<300 mg caffeine/day) guidelines, logistic regression for n = 59,123 in the Norwegian Mother and Child Cohort
Study, 2002 to 2009. SGA defined according to Marsal (ultrasound based), Skjaerven (population based) or Gardosi (customized).
aOR: odds ratio, compared to lowest caffeine intake group (0 to 50 mg/day).
bP value, logistic regression. Adjustment for maternal age, pre-pregnancy body mass index, parity, history of preterm delivery, baby’s sex, nausea during second
trimester, smoking habits, passive smoking, nicotine intake from other sources, alcohol consumption during pregnancy, energy intake, maternal education,
marital status and household income.
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consuming other caffeine sources, might be associated
with gestational length by some lifestyle factor.
The most important confounder on the behavioral level
is smoking. Smokers are known to have higher coffee con-
sumption [20]; furthermore, smoking is an established risk
factor for spontaneous PTD. According to our results, how-
ever, coffee drinking and smoking have opposing effects on
gestational length. The association with coffee intake
remained significant after adjusting for smoking and
excluding all smokers from the analysis, strongly suggesting
an association between coffee consumption and gestational
length that is independent of smoking behavior.
There was no major difference regarding the associa-
tion for coffee consumption during different periods of
pregnancy, suggesting either a rather continuous effect of
coffee drinking on gestational length or confounding of
coffee consumption with some other factor, as opposed
to coffee consumption at a specific timepoint affecting
some crucial step of pregnancy development.
In summary, we seem to have identified an association
for coffee rather than caffeine, which must be kept in
mind when discussing our findings in the context of ear-
lier publications. To the best of our knowledge, this study
is the first to separately study the associations between
gestational length and caffeine from coffee, on the one
hand, and caffeine from other sources, on the other. In
comparison, most observational studies have not found
any associations between caffeine or coffee and gestational
length [48-53] and Maslova et al. found no significant
association with overall PTD risk in their meta-analysis
[31]. There may be several reasons for the fact that we
found an association for coffee drinking, but not for
Table 8 Birth weight and maternal caffeine intake at different timepoints before and during pregnancy
Modela Caffeine source Birth weight (Marsal) Birth weight (Skjaerven) Birth weight (Gardosi)
b (g) 95% CI P value b (g) 95% CI P value b (g) 95% CI P value
Pre-pregnancy:
I Total -3 -5 to-2 <10-6 -2 -4 to-1 <10-3 -1 -3 to 0 0.04
Coffee, all types -3 -4 to-2 <10-4 -2 -3 to 0 0.02 -1 -3 to 0 0.07
Caffeinated soft drinksb -3 -7 to 1 0.1 -4 -8 to 0 0.06 -1 -5 to 3 0.6
Black tea -16 -23 to-9 <10-5 -16 -23 to-8 <10-4 -6 -13 to 1 0.1
II Total 1 -1 to 3 0.3 2 0 to 3 0.03 2 1 to 4 0.003
Coffee, all types 1 -1 to 3 0.2 2 0 to 4 0.02 3 1 to 4 <3 × 10-3
Caffeinated soft drinksb 4 -3 to 10 0.3 3 -3 to 10 0.3 5 -1 to 11 0.1
Black tea -12 -21 to-2 0.02 -13 -22 to-3 0.01 -3 -12 to 7 0.6
17th week of gestation:
I Total -9 -12 to-7 <10-17 -8 -10 to-6 <10-13 -7 -9 to-5 <10-10
Coffee, all types -9 -11 to-6 <10-11 -7 -10 to-5 <10-7 -7 -10 to-5 <10-8
Caffeinated soft drinksb -9 -15 to-4 <2 × 10-3 -10 -15 to-4 <10-3 -6 -11 to-1 0.03
Black tea -14 -22 to-6 <10-3 -12 -20 to-4 <5 × 10-3 -6 -14 to 2 0.13
II Total -8 -11 to-6 <10-8 -8 -10 to-5 <10-8 -7 -10 to-5 <10-8
Coffee, all types -8 -11 to-4 <10-5 -8 -11 to-4 <10-5 -7 -10 to-4 <10-4
Caffeinated soft drinksb -13 -22 to-5 <3 × 10-3 -13 -22 to-4 <4 × 10-3 -12 -20 to-3 <7 × 10-3
Black tea -1 -12 to 9 0.8 2 -9 to 13 0.8 -3 -14 to 7 0.5
30th week of gestation:
I Total -8 -10 to-6 <10-13 -7 -9 to-5 <10-10 -6 -8 to-4 <10-7
Coffee, all types -9 -11 to-6 <10-10 -7 -9 to-4 <10-7 -7 -10 to-5 <10-8
Caffeinated soft drinksb -2 -6 to 3 0.5 -3 -7 to 2 0.3 0 -5 to 4 0.9
Black tea -18 -27 to-10 <10-4 -18 -27 to-9 <10-4 -8 -16 to 1 0.08
II Total -5 -7 to-3 <10-4 -5 -7 to-3 <10-4 -4 -7 to-2 <10-3
Coffee, all types -6 -9 to-3 <10-3 -5 -9 to-2 <2 × 10-3 -6 -9 to-3 <10-4
Caffeinated soft drinksb -1 -6 to 5 0.8 -1 -6 to 4 0.7 0 -5 to 5 0.9
Black tea -14 -24 to-4 <5 × 10-3 -15 -25 to-5 <3 × 10-3 -6 -16 to 3 0.2
Birth weight (BW) and maternal caffeine intake reported at different timepoints before and during pregnancy (data from Q1 and Q3), linear regression for three
caffeine sources as well as total caffeine intake, n = 59,123 in the Norwegian Mother and Child Cohort Study, 2002 to 2009. b = BW gain (in g) per 100 mg
additional caffeine/day for a baby with an expected BW of 3,600 g.
aP value, linear regression adjusted as follows. Model I: maternal age, pre-pregnancy body mass index, parity, history of preterm delivery, baby’s sex, nausea
during second trimester, smoking habits, passive smoking, nicotine intake from other sources, alcohol consumption during pregnancy, energy intake, maternal
education, marital status, household income. In the analysis of the separate caffeine sources, these were mutually adjusted (coffee, caffeinated soft drinks, black
tea and chocolate). Model II: as model I, as well as for caffeine intake from different sources as reported at the other studied timepoints.
bCaffeinated soft drinks included in Q1 and Q3: Coca Cola/Pepsi with sugar, Coca Cola light, Pepsi Light.
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caffeine per se. We used self-reported caffeine intake
instead of measuring caffeine metabolites [49,50]. Caffeine
from several sources was assessed, rather than caffeine
intake from a single source, usually coffee, as in many stu-
dies [30,53-55]. For some populations using only caffeine
from coffee would implicate that a major, if not the major,
part of total caffeine intake was not considered at all, for
example, in a UK study black tea contributed 62% to daily
caffeine intake while coffee and cola drinks accounted for
about 12% to 14% each [45]. PTD is a heterogeneous
group of pregnancy outcomes with heterogeneous etiology
[32]. In contrast to the studies mentioned above, we
defined a clear spontaneous PTD phenotype by excluding
all iatrogenic deliveries as well as all medical or obstetric
complications. The etiologies of early and late spontaneous
PTD differ, which has not been acknowledged in many
other studies [20]. Mikkelsen et al. found an increased risk
of early, but not late, overall PTD related to coffee intake
of more than 2 cups/day in the Danish Birth Cohort [30],
while Haugen et al. failed to confirm these results in an
earlier version of MoBa [55]. In this study, in which only
spontaneous PTD in uncomplicated pregnancies was
investigated, black tea caffeine intake was significantly
associated with increased risk for early spontaneous PTD
while significant associations were not found for other caf-
feine sources, indicating that this association was not
caused by caffeine. The association with black tea caffeine
was only marginally significant and there was no signifi-
cant association between black tea caffeine and gestational
length so that these results should be interpreted with
caution.
In addition to the above-mentioned paper by Mikkelsen
et al., Klonoff-Cohen et al. reported decreased gestational
length related to caffeine consumption of >50 mg/day,
compared to 0 to 2 mg/day, in a sample of 39 pregnancies
[29]. To our knowledge, this study of 49,102 pregnancies
with spontaneous delivery is the biggest and most detailed
observational study so far on the association between caf-
feine intake and gestational length, particularly sponta-
neous PTD. Our data do not support the hypothesis that
caffeine intake or coffee consumption decrease gestational
length or increase the risk for spontaneous PTD. Although
we did find a significant association, a change in gesta-
tional length of several hours probably lacks clinical
implications.
Birth weight and SGA
We found significant associations between caffeine intake
and SGA and decreased BW. These associations were
strengthened by concordant results for different caffeine
sources, comparable overall findings regardless of the
growth standard and SGA definition applied, remaining
significance after adjustment, biological gradient, stability
over period of pregnancy, consistency with other studies
and biological plausibility. Caffeine is metabolized more
slowly during pregnancy, crosses the placental barrier [7]
and increases maternal levels of 3’5’-cyclic monopho-
sphate and epinephrine [56], causing uteroplacental vaso-
constriction and decreased intervillous placental blood
flow, which could restrict fetal growth [48,54]. Another
hypothesis, postulated by Weathersbee et al., is that caf-
feine inhibits phosphodiesterase, leading to an increase in
cellular cyclic adenosine monophosphate, which may
interfere with fetal growth [57].
Smoking is a difficult confounder when studying effects
of caffeine consumption [20]. Both smoking and caffeine
intake are associated with lower BW. However, the asso-
ciation between caffeine intake and BW remained highly
significant after adjustment for smoking and after analysis
in the non-smoker subgroup, suggesting an independent
association with caffeine consumption.
Caffeine intake reported at gestational week 17 was
most strongly associated with BW. This could be
explained by reverse causality, according to Lawson’s
hypothesis, that is, the placenta is comparatively smaller
in pregnancies complicated by SGA than in healthy preg-
nancies, thus producing less hormones and evoking
fewer pregnancy symptoms so that these women might
maintain a higher caffeine intake [20,58]. However,
remaining significance after controlling for nausea and
the finding of a significant association for pre-pregnancy
caffeine intake as well contradicts reverse causality as
only explanation.
While some earlier studies found no significant associa-
tion between caffeine consumption and BW [48,53,54,59],
most publications are consistent with our findings in
MoBa [49,50,60-63]. Especially the data from some of the
largest observational studies published so far, are consis-
tent with our findings, moreover with comparable effect
size of a decrease in BW by 60 to 70 g for >200 mg/day
[45] or 28 g for 100 mg/day caffeine consumption [50].
In this study population, more than 10% exceeded the
NNR recommended maximum intake of 200 mg/day; this
subgroup had 20% to 60% higher odds ratios for SGA.
Although SGA babies are generally known to be at higher
risk for both neonatal morbidity and mortality [24], this
might not be true for babies born SGA due to maternal
caffeine consumption. Hernandez-Diaz found that babies
born SGA due to maternal smoking might have lower
mortality than other SGA babies with more severe causes
for being born SGA, such as congenital malformations
[64]. However, as our results confirm earlier findings [45]
that the increase in SGA risk can already be found in
women following the current recommendations by Nor-
wegian Authorities, further studies are needed to establish
the impact of caffeine on neonatal morbidity and mortal-
ity. We could not find a threshold for the association of
caffeine consumption and SGA risk. Until there is clarity if
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there is a causal association between caffeine intake and
increased risk for SGA, women might be advised to reduce
their caffeine consumption as much as possible during
pregnancy.
Limitation and strengths
To the best of our knowledge, with its sample size of
59,123 pregnancies, this is the largest study performed so
far on the association between caffeine intake and preg-
nancy outcome. The MoBa participation rate is 38.5%, and
demographic comparison with the MBRN in 2002 showed
that single women and women aged <25 are underrepre-
sented in MoBa. Regarding SGA (4.6% in MoBa and 5.1%
in the MBRN) and PTD (7.2% in MoBa and 7.7% in the
MBRN), the differences are minor and the subgroup com-
position is similar to that in the total population, with
spontaneous PTD accounting for 42% of all PTD [28].
Additionally, a recent study found no bias in eight selected
exposure-outcome associations [65].
Due to the large study sample, there were 1,411 cases
defined as spontaneous PTD and 852 (Marsal), 4,503
(Skjaerven) or 4,733 (Gardosi) cases of SGA in the study
population. Estimation of gestational length by second-
trimester ultrasound and clear definition of a sponta-
neous PTD phenotype are additional strengths of this
study [20,24,32]. Different standard growth curves were
applied and this study is one of the first caffeine effect
studies using customized growth curves at all [20,45].
The overall results for all three models indicate an
adverse effect of caffeine consumption on SGA risk,
strengthening the association found.
All dietary assessment methods have limitations, and
so does the self-reported caffeine intake in this study.
The mean caffeine concentrations in seven main cate-
gories of food and drinks were used for the exposure
calculations, while large variations may actually exist
within each category [41]. The caffeine contributed by
soft drinks is likely to be underestimated as Coca Cola
and Pepsi (including their diet versions) were the only
soft drinks distinguished from other soft drinks in the
FFQ. However, some other soft drinks also contain caf-
feine, for example, Urge, a citrus flavored soft drink pro-
duced by Coca Cola Norway. However, this soft drink
comprised a rather small share of the market.
Relying exclusively on self-reported data without a bio-
logical marker to confirm the accuracy of estimated caf-
feine exposure is a weakness. For the present study we
evaluated the agreement between caffeine intake esti-
mated by the FFQ and a food diary. The estimated caf-
feine intake did not differ between the methods, and a
high correlation was observed (r = 0.70, 95% CI 0.59 to
0.78). Furthermore, the MoBa FFQ has been extensively
validated in a MoBa subpopulation using the four-day
weighed food diary and several biomarkers as reference
measures [42,43]. The agreement between the FFQ and
the food diary was particularly high for coffee and tea,
which are the main sources of caffeine in this study. Cof-
fee intake according to both the FFQ and the food diary
correlated with serum b-carotene (0.31 and 0.36, respec-
tively), which can be explained by interplay between anti-
oxidants in coffee with b-carotene, as also reported by
Svilaas et al.[66]. Likewise, tea intake according to both
the FFQ and the food diary correlated with kaempferol, a
flavonoid found in tea (r = 0.41 and 0.50 for the FFQ and
food diary, respectively [42]). Similar, but slightly weaker
correlations were observed for estimated caffeine contrib-
uted by coffee and tea. A Bland-Altman plot for the dif-
ferences in caffeine intake between the FFQ and the food
diary is available as Additional file 1.
There are further strengths related to the caffeine intake
assessment: the prospective design ensured that women’s
responses were not influenced by their knowledge of preg-
nancy outcome. Caffeine intake assessment from different
sources, as well as different coffee preparations being
taken into account, are also clear strengths of this study
[20]. As the FFQ covers the first four to five months of
pregnancy, when many women change their dietary habits
due to nausea, some women may have had difficulties
reporting the frequency and amount of caffeine consump-
tion for the whole period correctly. Coffee and black tea
intake varies less and is easier to recall than intake of most
other food groups. The associations with caffeine intake
based on the FFQ were corroborated by caffeine intake
estimates based on reported consumption of caffeine-con-
taining drinks in the other two questionnaires (Q1 and
Q3). As the relevant window of susceptibility for caffeine
effects is not yet known [20], caffeine consumption assess-
ment at different timepoints is a further strength of this
study.
There is always a possibility of residual confounding in
observational studies, but we reduced this possibility by
controlling for a number of relevant factors, including
history of PTD, nausea and smoking. Our smoking vari-
able has been shown to be a valid marker for tobacco use
when tested against plasma cotinine concentration [67].
Conclusions
Coffee intake is associated with slightly increased gesta-
tional length but does not affect the odds for sponta-
neous PTD. It is not caffeine, however, that is the cause
of this association. Whether it is some other substance
present in coffee, but not in other caffeine sources, or
whether coffee drinking is associated, on a behavioral
level, with some factor influencing gestational length
remains to be further investigated.
Caffeine intake is associated with decreased BW and
increased odds for SGA. These associations are strength-
ened by concordant results for different caffeine sources,
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comparable overall findings regardless of the growth curve
or definition of SGA, remaining significance after adjust-
ment, stability over period of pregnancy, consistency with
other studies and biological plausibility. These SGA babies
might be at higher risk for both short-term and long-term
morbidity. As the risk for SGA increases even if pregnant
women follow official recommendations in Norway of a
maximum caffeine intake of 200 mg/day, this association
should be further investigated and recommendations
might have to be re-evaluated.
Additional material
Additional file 1: Bland-Altman plot for the difference in caffeine
intake between the food frequency questionnaire (FFQ) and a four-
day weighed food diary in 119 women in the validation study.
Bland-Altman plot of the differences in caffeine intake between the FFQ
and the food diary measurements (bias) against the mean caffeine intake
by the two methods showing that the mean difference was small and
not biased towards any of the methods. The median (IQR) caffeine intake
in the validation study sample was 40 mg/day (18 to 88 mg/day) by the
FFQ and 38 mg/day (10 to 99 mg/day) by the food diary. Spearman
correlation was 0.70 (95% CI 0.59 to 0.78).
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